Top News

Jun 12, 2017
The landmark decision determined that biosimilar makers can notify manufacturers before receiving FDA approval.
Jun 08, 2017
FDA asked Endo Pharmaceuticals to remove Opana ER from the market, citing the potential for abuse.
May 15, 2017
By BioPharm International Editors
Thermo Fisher will acquire Patheon for approximately $7.2 billion, including the assumption of approximately $2 billion of net debt.
May 09, 2017
User fee reauthorizations, a hiring freeze, and opioid epidemic await the new FDA commissioner Scott Gottlieb.
May 05, 2017
By BioPharm International Editors
Forecasts were lowered, Reuters reported, due to reduced drug approvals and increased competitive pressures.
May 05, 2017
By BioPharm International Editors
The program aims to make biosimilars for the treatment of cancer more widely available in middle- and low-income countries.
Apr 21, 2017
The agency approved Renflexis, a biosimilar to Janssen’s blockbuster rheumatoid arthritis treatment.
Apr 13, 2017
UC Berkeley appealed the February 2017 decision that determined Harvard and MIT’s Broad Institute and Berkeley’s CRISPR-Cas9 technologies were separately patentable.
Mar 29, 2017
The mAb is the first approved treatment that targets the progressive form of the disease.
Mar 16, 2017
By BioPharm International Editors
Human antibody for Zika virus could help in the treatment and prevention of the infection.
native1_300x100
lorem ipsum